Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Therapy

Arming the regulators — new strategies to treat autoimmunity

Nature Reviews Rheumatology volume 14, pages 188–189 (2018)Cite this article

Subjects

A great deal of interest exists in the use of regulatory T cells for therapeutic purposes in autoimmune diseases such as rheumatoid arthritis. Two new studies highlight possible approaches to achieve this aim, but the jury is still out on whether these will become effective therapies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Harnessing the immunomodulatory properties of regulatory T cells.

References

  1. van Vollenhoven, R. F. et al. Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial. Ann. Rheum. Dis. http://ard.bmj.com/content/77/4/495 (2018).

  2. Fischer, R. et al. Selective activation of tumor necrosis factor receptor 2 induces anti-inflammatory responses and alleviates experimental arthritis. Arthritis Rheumatol. https://doi.org/10.1002/art.40413 (2018).

    Article  CAS  Google Scholar 

  3. Klatzmann, D. & Abbas, A. K. The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases. Nat. Rev. Immunol. 15, 283–294 (2015).

    Article  CAS  Google Scholar 

  4. Trzonkowski, P. et al. Hurdles in therapy with regulatory T cells. Sci. Transl Med. 7, 304ps18 (2015).

    Article  Google Scholar 

  5. Chen, X. & Oppenheim, J. J. TNF-α: an activator of CD4+FoxP3+TNFR2+ regulatory T cells. Curr. Dir. Autoimmun. 11, 119–134 (2010).

    Article  CAS  Google Scholar 

  6. Vanamee, E. S. & Faustman, D. L. TNFR2: a novel target for cancer immunotherapy. Trends Mol. Med. 23, 1037–1046 (2017).

    Article  CAS  Google Scholar 

  7. Zhou, X. et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol 10, 1000–1007 (2009).

    Article  CAS  Google Scholar 

  8. Cribbs, A. P. et al. Regulatory T cell function in rheumatoid arthritis is compromised by CTLA-4 promoter methylation resulting in a failure to activate the IDO pathway. Arthritis Rheumatol. 66, 2344–2354 (2014).

    Article  CAS  Google Scholar 

  9. Quan, Z. et al. Interleukin 6 induces cell proliferation of clear cell renal cell carcinoma by suppressing hepaCAM via the STAT3-dependent up-regulation of DNMT1 or DNMT3b. Cell Signal. 32, 48–58 (2017).

    Article  CAS  Google Scholar 

  10. McCann, F. E. et al. Selective tumor necrosis factor receptor I blockade is antiinflammatory and reveals immunoregulatory role of tumor necrosis factor receptor II in collagen-induced arthritis. Arthritis Rheumatol. 66, 2728–2738 (2014).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

W.-Y.T. has received funding from Chang Gung Memorial Hospital (CMRPG2D0251- CMRPG2D0253).

Author information

Authors and Affiliations

  1. Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK

    Richard O. Williams & Wen-Yi Tseng

Authors
  1. Richard O. Williams
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wen-Yi Tseng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Richard O. Williams.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Williams, R., Tseng, WY. Arming the regulators — new strategies to treat autoimmunity. Nat Rev Rheumatol 14, 188–189 (2018). https://doi.org/10.1038/nrrheum.2018.50

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2018.50

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing